Tradestie Institutional Equity Comparison Engine
CELU vs ABEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Overall Edge
ABEO Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CELU trades at N/M Forward P/E with -254.0% operating margin (-5.3% YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, CELU sits in BREAKDOWN (50th %ile IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
ABEO
CELU N/M vs ABEO 18.7x Fwd P/E
Growth & Margin Winner
ABEO
Op Margin -254.0% vs -186.1% ยท YoY -5.3% vs +2745.0%
Momentum & Technical Winner
ABEO
1Y -72.6% vs -42.4% ยท 52W Pos 2% vs 6%
Options & Structure Winner
ABEO
BREAKDOWN (50th %ile IV) vs BREAKDOWN (27th %ile IV)
CELU
NASDAQ
Celularity Inc. Class A Common Stock
Pharmaceutical Preparations
$0.46
-1.05% 1D
Market Cap
$15.2M
1M Return
-55.9%
1Y Return
-72.6%
Forward P/E
N/M
Unified AI Score
42.9 / 100
HOLD
Tech 25.0
Fund 48.0
Flow 67.0
Mom 55.0
ABEO
NASDAQ
Abeona Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$2.42
-1.22% 1D
Market Cap
$167.4M
1M Return
-45.86%
1Y Return
-42.38%
Forward P/E
18.7x
Unified AI Score
49.9 / 100
HOLD
Tech 60.0
Fund 61.0
Flow 67.0
Mom 55.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CELU -72.6%
ABEO -42.38%
Spread: +30.22 pp (ABEO Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CELU Revenue | ABEO Revenue | CELU Op. Margin | ABEO Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2017 | N/A | $0M | N/A | -3325.7% | ABEO |
| FY2018 | N/A | $0M | N/A | -1940.2% | ABEO |
| FY2020 | $10M | $10M | -1064.0% | -814.2% | ABEO |
| FY2021 | $20M | $0M | -511.2% | -2994.5% | CELU |
| FY2022 | $20M | $0M | -142.4% | -3600.8% | CELU |
| FY2023 | $20M | $0M | -844.4% | -1346.7% | CELU |
| FY2024 | $50M | N/A | -70.7% | N/A | CELU |
| FY2025 | $30M | $10M | -230.9% | -1536.9% | CELU |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CELU | ABEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.2M | $167.4M | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | -5.3% | +2745.0% | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | -254.0% | -186.1% | Higher Margin | ABEO |
| Net Profit Margin Profitability | -245.7% | -160.3% | Higher Margin | ABEO |
| Return on Equity (ROE) Capital Efficiency | -6367.2% | -42.1% | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 2% ($0โ$3) | 6% ($2โ$8) | Stronger Trend | ABEO |
| Beta / 30D Volatility Risk Regime | 2.01ฮฒ ยท 135% Vol | 0.60ฮฒ ยท 149% Vol | Lower Realized Risk | CELU |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 49.9 / 100 (HOLD) | Higher Composite | ABEO |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CELU vs ABEO Buy Guide
CELU
BREAKDOWN
60d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
50th %ile
IV Regime
Balanced (25thโ60th %ile)
ABEO
BREAKDOWN
71d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
27th %ile
IV Regime
Balanced (25thโ60th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CELU nor ABEO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.